Sacha , T. (2014). Deep molecular response (MR4.5) as a target of therapy with tyrosine kinase inhibitors. MR4.5 – goal of CML treatment. OncoReview, 4(1(13), 26-32. Retrieved from https://journalsmededu.pl/index.php/OncoReview/article/view/356